These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12135935)

  • 1. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy.
    Cipollone F; Mezzetti A; Porreca E; Di Febbo C; Nutini M; Fazia M; Falco A; Cuccurullo F; Davì G
    Circulation; 2002 Jul; 106(4):399-402. PubMed ID: 12135935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia.
    Sanguigni V; Ferro D; Pignatelli P; Del Ben M; Nadia T; Saliola M; Sorge R; Violi F
    J Am Coll Cardiol; 2005 Jan; 45(1):35-42. PubMed ID: 15629370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
    Leo R; Di Lorenzo G; Tesauro M; Razzini C; Forleo GB; Chiricolo G; Cola C; Zanasi M; Troisi A; Siracusano A; Lauro R; Romeo F
    J Clin Psychiatry; 2006 Nov; 67(11):1760-6. PubMed ID: 17196057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
    Lim HS; Blann AD; Lip GY
    Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):463-7. PubMed ID: 15311154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease.
    Koutroubakis IE; Theodoropoulou A; Xidakis C; Sfiridaki A; Notas G; Kolios G; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1147-52. PubMed ID: 15489574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
    Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
    Acta Cardiol; 2006 Jun; 61(3):263-9. PubMed ID: 16869445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
    Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
    J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin.
    Pignatelli P; Sanguigni V; Lenti L; Loffredo L; Carnevale R; Sorge R; Violi F
    J Thromb Haemost; 2007 Jun; 5(6):1170-8. PubMed ID: 17388962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased soluble CD40 ligand levels in cystic fibrosis.
    Falco A; Romano M; Iapichino L; Collura M; Davì G
    J Thromb Haemost; 2004 Apr; 2(4):557-60. PubMed ID: 15102009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
    Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
    Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand: a novel target in the fight against cardiovascular disease.
    Vishnevetsky D; Kiyanista VA; Gandhi PJ
    Ann Pharmacother; 2004 Sep; 38(9):1500-8. PubMed ID: 15280513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.
    Han SH; Koh KK; Quon MJ; Lee Y; Shin EK
    Atherosclerosis; 2007 Jan; 190(1):205-11. PubMed ID: 16500662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of resveratrol on platelet activation in hypercholesterolemic rats: CD40-CD40L system as a potential target.
    Göçmen AY; Burgucu D; Gümüşlü S
    Appl Physiol Nutr Metab; 2011 Jun; 36(3):323-30. PubMed ID: 21574786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia.
    Garlichs CD; John S; Schmeisser A; Eskafi S; Stumpf C; Karl M; Goppelt-Struebe M; Schmieder R; Daniel WG
    Circulation; 2001 Nov; 104(20):2395-400. PubMed ID: 11705814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD40 ligand plasma levels in lung cancer.
    Roselli M; Mineo TC; Basili S; Martini F; Mariotti S; Aloe S; Del Monte G; Ambrogi V; Spila A; Palmirotta R; D'Alessandro R; Davì G; Guadagni F; Ferroni P
    Clin Cancer Res; 2004 Jan; 10(2):610-4. PubMed ID: 14760083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.